Please login to the form below
Accelerated Access Collaborative
This page shows the latest Accelerated Access Collaborative news and features for those working in and with pharma, biotech and healthcare.
England to fast-track tumour agnostic drugs like Vitrakvi – if the price is right
be keen to see the arrival of Roche’s rival entrectinib, to allow greater leverage in market access negotiations. ... We welcome NHS England, government and other partners working together as part of the Accelerated Access Collaborative to address some
Latest news
-
Roche Diagnostics among beneficiaries as NHS fast-tracks more tech
Many of the chosen products are also being promoted by the Accelerated Access Collaborative (AAC), which also includes novel medicines on its fast-track list.
-
England opens new NHS ‘front door’ to health innovators
An upgrade to existing ACC initiative. The UK government has unveiled an upgrade to its Accelerated Access Collaborative (ACC) initiative, aimed at creating a single ‘front door’ into the NHS for ... support the NHS to more quickly adopt clinically
-
MS and cholesterol drugs picked for new UK rapid uptake push
Accelerated Access Collaborative aims to break down barriers to faster uptake. ... The medicines have been chosen by the Accelerated Access Collaborative (ACC) a new initiative aimed at speeding up access to healthcare innovation which could improve
-
Daily Brief: Andrew Witty's replacement on Accelerated Access initiative, Blincyto gains full EU approval and more
The Accelerated Access Collaborative (AAC) was meant to have started work in April, but since former GSK chief executive Sir Andrew Witty stepped down as its chair, the initiative has been ... Lord Darzi, Chair of the Accelerated Access Collaborative,
-
Ex-GSK head Witty to head group overseeing UK fast-track scheme
Witty has been chosen to chair the Accelerated Access Collaborative (AAC), an organisation that will have the responsibility to coordinate the various government bodies that will decided which new treatments should ... be selected for the Government’s
More from news
Approximately 3 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
25 Women Leaders in UK Healthcare
with a rare condition for which there is no diagnosis, or no treatment, or where there is no access to new therapies on the NHS. ... Dr Roberts is now switching roles to become chief executive of the Accelerated Access Collaborative (AAC).
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
Patient Access Schemes (PAS), both of which were previously the domain of the DHSC. ... Sciences Council, the NICE Implementation Collaborative (NICE) and the Accelerated Access Collaborative (AAC).
-
New models of NHS care – new models of pharma response?
The Accelerated Access Collaborative. Ewan Barbour, Market Access and Pricing Director, Merck, presented on its multiple sclerosis treatment Mavenclad being selected to be among the first designated Rapid Uptake products on ... the new Accelerated Access
-
Pharma: in search of the sustainable ‘win win’ with the NHS
Update: Ewan Barbour, Market Access and Pricing Director at Merck will also be speaking at the event. ... The company has just secured 'Rapid Uptake' status for its multiple sclerosis drug Mavenclad via the new Accelerated Access Collaborative process.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
How is the NHS Long-term Plan being put into action?
Among the changes is the right for all patients to access online or video consultations within the next few years. ... the Government recently announced changes to the Accelerated Access Collaborative (AAC), to ensure that the most promising medicines,
-
Spotlight on innovation at life sciences forum
We will also hear from the Accelerated Access Collaborative (AAC), which was set up in 2018 to reduce the amount of time it takes for patients to benefit from ground-breaking ... Accelerated Access Collaborative(AAC). Since its recent inception, the AAC
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
